Pharmaresearch Bio Co (XKRX:217950) Current Deferred Taxes Liabilities : ₩0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Pharmaresearch Bio Co's current deferred tax liabilities for the quarter that ended in Dec. 2023 was ₩0 Mil.

Pharmaresearch Bio Co Current Deferred Taxes Liabilities Historical Data

The historical data trend for Pharmaresearch Bio Co's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Current Deferred Taxes Liabilities Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Pharmaresearch Bio Co Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co (XKRX:217950) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines